TXMD·88338N206·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
TXMD (THERAPEUTICSMD INC) is held by 24 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($295,324), MORGAN STANLEY ($261,018), BlackRock, Inc. ($232,593). Net institutional sentiment: Mixed.
See how TXMD's score breaks down across 4 SEC sources
Showing 1-20 of 26
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer